An Indian drugmaker has applied for Emergency Use Approval (EUA) for its Covid-19 vaccine, which is administered in a three-dose regimen. The firm claims the shot is the first ever plasmid DNA vaccine. In a press statement on Thursday, Indian pharmaceutical giant Zydus Cadila said it had conducted India’s largest Covid-19 vaccine trial to date when testing the effectiveness and safety of its new shot. The trial, it says, took place during the wave caused by the Delta variant. Comment: Black fungus cases surge in India, mostly in patients who recovered from coronavirus The firm stated that they had applied …read more
Source: Sott health news feed
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr